🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Severe Aplastic Anemia (SAA) is a rare and very serious blood disorder in w...
Status
Completed
Location
National Institutes of Health Clinical Center, 9000 Rockville Pike
Start Date
1997-06-02
Trial ID
NCT00001626
Treatments Being Tested
Purpose: There remains a great need for novel therapeutic agents and treatm...
Status
Completed
Location
Massachusetts General Hospital
Start Date
2005-07
Trial ID
NCT00130689
Treatments Being Tested
This phase II trial studies the best approach to combine chemotherapy and r...
Status
Recruiting
Location
Children's Hospital of Alabama
Start Date
2021-07-13
Trial ID
NCT04684368
RATIONALE: Drugs used in chemotherapy, work in different ways to stop the g...
Status
Completed
Location
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Start Date
2005-07
Trial ID
NCT00133991
RATIONALE: Bortezomib may stop the growth of myeloma cells by blocking prot...
Status
Unknown
Location
The Second Affiliated Hospital of Soochow University
Start Date
2013-12
Trial ID
NCT02027220
Treatments Being Tested
This study is a prospective, randomized phase III, to evaluate if in patien...
Status
Active Not Recruiting
Location
Ospedale San Salvatore
Start Date
2021-04-30
Trial ID
NCT04776655
Treatments Being Tested
The purpose of this study is to evaluate (Abatacept) for treatment of lupus...
Status
Terminated
Location
University Of Alabama At Birmingham (Uab)
Start Date
2013-01-22
Trial ID
NCT01714817
Treatments Being Tested
Ascorbic acid (Vitamin C) could protect renal toxicity from colistin....
Status
Unknown
Location
Siriraj Hospital
Start Date
2012-01
Trial ID
NCT01501968
Treatments Being Tested
This is a Phase I/II, single-arm, open-label, multi-center study to evaluat...
Status
Recruiting
Location
Beijing Cancer Hospital
Start Date
2026-08-12
Trial ID
NCT07790510
RATIONALE: Gene-modified lymphocytes may stimulate the immune system in dif...
Status
Terminated
Location
Warren Grant Magnuson Clinical Center - NCI Clinical Trials Referral Office
Start Date
2008-06
Trial ID
NCT00704938